Multiple Myeloma — Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse
Citation(s)
Assessment of the Antitumour Effect of Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse: Prospective Clinical Trial of the GEM/PETHEMA Group